Stryker Neurovascular
Clinical trials sponsored by Stryker Neurovascular, explained in plain language.
A subsidiary of Stryker, focused on neurovascular medical devices.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New coil device aims to seal brain aneurysms without surgery Results expected Nov 2026 (estimated)